GLP-1 mimics Trending A Pancreatic Cancer Vaccine Shows Promise in a Phase 1 Clinical Trial A new peptide-based vaccine elicited antigen-specific T cell responses in high-risk patients, demonstrating proof of concept for PDAC intervention
BPC-157 Peptide: Benefits, Dosing & Professional Therapy Last updated: March 17, 2026 Key Takeaways BPC-157 is a synthetic peptide fragment from gastric juice that supports tissue repair, angiogenesis, and reduced inflammation in animal studies
Safety, Side Effects, and Medical Supervision Requirements GLP-1 medications are generally well-tolerated, but nausea, vomiting, and constipation occur frequently during titration
Retatrutide appears particularly effective in patients with significant insulin resistance and metabolic dysfunction, where its comprehensive receptor activation provides maximal benefit
Due to its dual-action mechanism, some people may experience more pronounced gastrointestinal symptoms compared to semaglutide, he says